Phytochemical Name : Ocimum basilicum (OB) extract

Properties Information
PhytoCAT-ID PhytoCAT-1146
Phytochemical name or plant extracts Ocimum basilicum (OB) extract
PMID 25554015
Literature evidence OBL exhibited the highest antioxidant and antiproliferative activities. OB extracts not only improve taste but also have certain anticancer activity against diverse cancer cells due to the presence of compounds such as rosmarinic acid, chicoric acid and caftaric acid. Thus, OB represents a potent source of anticancer materials.
IUPAC name NA
Phytochemicals’ class or type of plant extracts Aqueous extract and Methanolic extract
Source of phytochemicals or plant Extracts Ocimum basilicum
Geographical availability Andaman Is., Assam, Bangladesh, Bismarck Archipelago, Borneo, Cambodia, China South-Central, China Southeast, East Himalaya, India, Jawa, Laos, Lesser Sunda Is., Malaya, Maluku, Myanmar, Nepal, New Guinea, Nicobar Is., Philippines, Queensland, Sri Lanka, Sulawesi, Sumatera, Taiwan, Thailand, Vietnam, West Himalaya, Western Australia
Plant parts Leaves
Other cancers Breast cancer, Cervical cancer, Pancreatic cancer
Target gene or protein AMPK
Gene or Protein evidence The treatment with both extracts also activated AMPK, but OB was much more efficient than OG in promoting this.
Target pathways Ocimum basilicum but not Ocimum gratissimum present cytotoxic effects on human breast cancer cell line MCF-7, inducing apoptosis and triggering mTOR/Akt/p70S6K pathway. The activation of mTOR signaling, another survival pathway was promoted by OB, whereas OG failed to activate it.
IC50 250 µg/mL against MCF-7
Potency In the end, we conclude that OB extract is efficient against the human breast cancer cell line.
Cell line/ mice model HeLa, MCF-7, Jurkat, HT-29, T24, MIAPaCa-2
Additional information  NA
PubChem ID NA
Additional PMIDs 29589262 33407904
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:452874-1
Safety NA